Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

GLENMARK PHARMS · OLOPATADINE HYDROCHLORIDE

ANDA219557Generic (ANDA)Over-the-counter
Open FDA's page for this record
Application number
ANDA219557
Sponsor name
GLENMARK PHARMS
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20250228
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    OLOPATADINE HYDROCHLORIDE
    Reference standard
    No
    Dosage form
    SOLUTION/DROPS
    Route
    OPHTHALMIC
    Marketing status
    Over-the-counter
    Active ingredients
    1. Name
      OLOPATADINE HYDROCHLORIDE
      Strength
      EQ 0.2% BASE
Harmonized identifiers (openFDA)
Application number
ANDA219557
Brand name
OLOPATADINE HYDROCHLORIDE, EYE ALLERGY ITCH RELIEF
Generic name
OLOPATADINE HYDROCHLORIDE, EYE ALLERGY ITCH RELIEF
Manufacturer name
GLENMARK THERAPEUTICS INC., USA, AmerisourceBergen Drug Corp, Allegiant Health, BluePoint Laboratories, YYBA Corp
Product NDC
72657-194, 46122-824, 69168-495, 68001-674, 73581-709
Product type
HUMAN OTC DRUG
Route
OPHTHALMIC
Substance name
OLOPATADINE HYDROCHLORIDE
RxCUI
1111343
SPL ID
5ce14b14-b893-4d56-a19e-b1788b17074f, 18f851e3-24c6-44fd-8376-0f5418ded9a9, bbb1ba80-f5f6-4fb5-9984-67718167625d, 4ddbb9c6-87d6-317b-e063-6294a90a7375, 49eedab1-1b39-61af-e063-6394a90a2dc6
SPL set ID
07e8b359-d4ae-4b5b-81dc-c7e57e172c58, 18f851e3-24c6-44fd-8376-0f5418ded9a9, b40bf37a-da62-4ef7-8722-33a3a0f67c64, 3e86783f-0001-625f-e063-6294a90acd20, 47f8ae9b-d92b-4bcb-e063-6294a90af45a
Package NDC
72657-194-25, 72657-194-11, 46122-824-29, 69168-495-77, 68001-674-92, 73581-709-02
UNII
2XG66W44KF
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.